• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 436575 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416858624 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416858624 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Bid Up Shares of Acorda Therapeutics, Up 2.4%

Published on Tue, 02/05/2013 - 13:17
By Peter Chu

Acorda Therapeutics (NASDAQ:ACOR) is one of today's biggest movers, up 2.4% to $29.35. The Dow Jones Industrial Average is now trading 0.7% higher to 13,984 and the S&P is trading 0.9% higher to 1,509.

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Acorda Therapeutics (NASDAQ:ACOR) has potential upside of 5.2% based on a current price of $29.35 and analysts' consensus price target of $30.88. The stock should discover initial support at its 50-day moving average (MA) of $26.45 and subsequent support at its 200-day MA of $24.61.

Acorda Therapeutics share prices have moved between a 52-week high of $29.79 and a 52-week low of $21.04 and are now trading 39% above that low price at $29.35 per share. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 1.0%.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Buyers Accumulate Shares of Cresud SACIF...

Cresud SACIF (NASDAQ:CRESY) is one of today's biggest movers, up 1.8% to $11.24. The S ...

Buyers Accumulate Shares of Bed Bath & B...

Up 1.8% to $73.60, Bed Bath & Beyond (NASDAQ:BBBY), is one of today's notable movers. ...

MarketAxess Holdings Shares Climbing Hig...

MarketAxess Holdings (NASDAQ:MKTX) is one of today's notable stocks on the rise, up 1.8 ...

Cablevision Systems Makes a Move: Up 1.8...

One of today's notable stocks on the rise is Cablevision Systems (NYSE:CVC), up 1.8% to ...

Stock Investors Bid Up Shares of Pricesm...

Pricesmart (NASDAQ:PSMT) is one of today's biggest movers, up 1.8% to $95.74. The Dow ...

Stock Investors Bid Up Shares of Steven ...

Steven Madden (NASDAQ:SHOO) is one of today's notable stocks on the rise, up 1.8% to $3 ...

Murphy Oil Shares Sinking Lower, Down 1....

Murphy Oil (NYSE:MUR) is a company whose shares are active, trading 1.8% lower to $53.0 ...

Shares of Golar LNG Receive a Boost, Up ...

Golar LNG (NASDAQ:GLNG) is a company whose shares are active, trading 1.8% higher to $5 ...